NASDAQ:SLGL - Sol Gel Technologies News Headlines Sign in or create an account to add this stock to your watchlist. Get Started $6.98 +0.22 (+3.25 %) (As of 07/17/2018 04:00 PM ET)Previous Close$6.76Today's Range$6.76 - $7.0152-Week Range$6.18 - $16.48Volume34,806 shsAverage Volume16,259 shsMarket Capitalization$131.89 millionP/E Ratio-1.39Dividend YieldN/ABetaN/A Company ProfileAnalyst RatingsEarnings HistoryHeadlinesOptions ChainSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Headlines Sol Gel Technologies (NASDAQ SLGL) News Headlines Source: All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance DateHeadlineSol Gel Technologies (SLGL) Research Coverage Started at HC Wainwrightwww.americanbankingnews.com - July 16 at 10:06 AMSol Gel Technologies Ltd (SLGL) Given Consensus Rating of "Buy" by Analystswww.americanbankingnews.com - July 16 at 9:13 AM Sol Gel Technologies Ltd (SLGL) Receives Average Rating of "Buy" from Brokerageswww.americanbankingnews.com - July 16 at 9:08 AMHead-To-Head Review: Perrigo (PRGO) and Sol Gel Technologies (SLGL)www.americanbankingnews.com - July 11 at 8:10 PMSol Gel Technologies Ltd (SLGL) Expected to Post Earnings of -$0.47 Per Sharewww.americanbankingnews.com - July 11 at 12:18 AMBrokerages Anticipate Sol Gel Technologies Ltd (SLGL) to Post ($0.47) Earnings Per Sharewww.americanbankingnews.com - July 1 at 7:36 AM Analysts Anticipate Sol Gel Technologies Ltd (SLGL) to Post -$0.47 Earnings Per Sharewww.americanbankingnews.com - June 23 at 3:26 PMSol-Gel launches late-stage development of Epsolay for rosaceaseekingalpha.com - June 19 at 9:54 AMSol-Gel Technologies Initiates Pivotal Phase III Clinical Program for Papulopustular Rosaceafinance.yahoo.com - June 19 at 9:54 AM Brokerages Set $19.00 Price Target for Sol Gel Technologies Ltd (SLGL)www.americanbankingnews.com - June 16 at 5:38 AMCritical Contrast: Sol Gel Technologies (SLGL) versus Its Rivalswww.americanbankingnews.com - June 7 at 9:06 PMZacks: Brokerages Expect Sol Gel Technologies Ltd (SLGL) Will Announce Earnings of -$0.47 Per Sharewww.americanbankingnews.com - June 6 at 11:33 AMZacks: Sol Gel Technologies Ltd (SLGL) Given Average Recommendation of "Buy" by Brokerageswww.americanbankingnews.com - June 1 at 5:43 AMFinancial Survey: Sol Gel Technologies (SLGL) versus Its Rivalswww.americanbankingnews.com - May 31 at 11:28 AMSol-Gel Technologies Announces Participation in Upcoming Investor Conferencesfinance.yahoo.com - May 30 at 8:58 AMSol Gel Technologies (SLGL) Lowered to "Sell" at Zacks Investment Researchwww.americanbankingnews.com - May 19 at 1:52 PMQ2 2018 EPS Estimates for Sol Gel Technologies Ltd (SLGL) Increased by Analystwww.americanbankingnews.com - May 18 at 7:08 AMZacks: Brokerages Set $19.00 Price Target for Sol Gel Technologies Ltd (SLGL)www.americanbankingnews.com - May 17 at 1:49 PMSol-Gel Technologies Reports First Quarter 2018 Financial Resultsfinance.yahoo.com - May 16 at 8:23 AMSol Gel Technologies (SLGL) Upgraded at ValuEnginewww.americanbankingnews.com - May 2 at 6:12 PMZacks: Sol Gel Technologies Ltd (SLGL) Given $19.00 Consensus Target Price by Brokerageswww.americanbankingnews.com - May 2 at 3:34 PMSol Gel Technologies Ltd (SLGL) Expected to Announce Earnings of -$0.33 Per Sharewww.americanbankingnews.com - May 2 at 3:22 PMHow Do Analysts See Sol-Gel Technologies Ltd (NASDAQ:SLGL) Performing Over The Next Few Years?finance.yahoo.com - May 2 at 8:02 AMGlobal Ceramic Coatings Market Report 2017-2025 Segmented by Application, Technology and Type - ResearchAndMarkets.comwww.businesswire.com - March 28 at 3:19 PMSol-Gel Technologies Ltd. Availability of Its Annual Report on Form 20-F Through Its Websitefinance.yahoo.com - March 27 at 6:52 AMSol-Gel Technologies Reports Fourth Quarter and Full Year 2017 Financial Resultsfinance.yahoo.com - March 26 at 3:18 PMAcne Vulgaris Therapeutics Global Pipeline Analysis Report 2017www.bizjournals.com - March 16 at 6:32 AMDermira shares drop 66% after surprise acne clinical trial failurewww.marketwatch.com - March 6 at 3:18 PMSol Gel Technologies Ltd's (SLGL) Quiet Period Will End on March 13thwww.americanbankingnews.com - March 6 at 1:02 AMBrokers Set Expectations for Sol Gel Technologies Ltd's FY2017 Earnings (SLGL)www.americanbankingnews.com - February 28 at 8:06 AMSol Gel Technologies (SLGL) Coverage Initiated at Jefferies Groupwww.americanbankingnews.com - February 26 at 8:46 PMJMP Securities Starts Sol Gel Technologies Ltd. (SLGL) at Market Outperformwww.streetinsider.com - February 26 at 3:16 PMSol Gel Technologies (SLGL) Receives New Coverage from Analysts at BMO Capital Marketswww.americanbankingnews.com - February 26 at 1:38 PMSol Gel Technologies (SLGL) Earns Market Outperform Rating from Analysts at JMP Securitieswww.americanbankingnews.com - February 26 at 1:30 PMBiotechs Take The Podium With The Year's 3 Best IPOsseekingalpha.com - February 22 at 3:16 PMSol-Gel’s Phase 2 Data on TWIN and VERED to be Presented at the 2018 American Academy of Dermatology Annual Meetingfinance.yahoo.com - February 16 at 5:18 AMSol-Gel Technologies Ltd. Announces Pricing of Initial Public Offeringfinance.yahoo.com - February 14 at 4:39 PMSol-Gel Technologies Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Sharesfinance.yahoo.com - February 14 at 4:39 PMSol-Gel Technologies (SLGL) to Raise $60 Million in IPOwww.americanbankingnews.com - January 24 at 1:08 AM This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: Should you buy a closed-end mutual fund?